# Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects

> **NCT03882112** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 24 (actual)

## Conditions studied

- Heathy Volunteer

## Interventions

- **DRUG:** HIP1601 40mg

## Key facts

- **NCT ID:** NCT03882112
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-17
- **Primary completion:** 2019-08-28
- **Final completion:** 2019-08-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882112, "Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03882112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*